NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) — Brilliant Acquisition Corporation (Nasdaq: BRLI) (“Brilliant or the Company”), a publicly traded special purpose acquisition company incorporated in the British Virgin Islands, announced today that a Statement on Form S-4 (the “Registration Statement”) in connection with its previously announced proposed business combination (the “Business Combination”) with Nukkleus, Inc. (f /k/a Compliance & Risk Management Solutions Inc.) (“Nukkleus”), has been filed by Nukkleus with the United States Securities and Exchange Commission (“SEC”). The registration statement (#333-264334) provides important information about Brilliant, Nukkleus and the business combination.

About Brilliant Acquisition Corp.

Brilliant (Nasdaq: BRLI) is a blank check corporation organized for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combinations with one or more companies or entities.

Additional information and where to find it

This press release relates to a proposed business combination transaction between Nukkleus and Brilliant pursuant to which Nukkleus will become the parent company of Brilliant upon closing of the transactions. In connection with the proposed transaction, Nukkleus has filed the registration statement with the SEC. The definitive proxy statement (if any) will be delivered to shareholders of Nukkleus and Brilliant. Nukkleus and Brilliant may also file other relevant documents regarding the proposed transaction with the SEC. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, INVESTORS AND SECURITY HOLDERS OF NUKKLEUS AND BRILLIANT ARE ADVISED TO READ THE REGISTRATION STATEMENT, PROXY ANNOUNCEMENT AND ALL OTHER RELEVANT DOCUMENTS FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION, INCLUDING ANY AMENDMENTS OR ADDITIONS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.

Investors and security holders may obtain free copies of the proxy statement and other documents filed or to be filed with the SEC by Nukkleus or Brilliant through the website operated by the SEC at www.sec.gov. Nukkleus shareholders may also obtain a copy of the definitive proxy statement, free of charge, by sending a request to: Nukkleus, Inc., 525 Washington Boulevard, Jersey City, New Jersey 07310. Brilliant shareholders may also obtain a copy of the definitive proxy statement, free of charge by sending a request to: Brilliant Acquisition Corporation, 99 Dan Ba ​​Road, C-9, Putuo District, Shanghai, People’s Republic of China.

Participants in the solicitation

Nukkleus and its directors and officers are participating in the solicitation of proxies from Nukkleus shareholders regarding the proposed transaction. Information about the directors and officers of Nukkleus and their ownership of Nukkleus common stock is set forth in Nukkleus’ Annual Report on Form 10-K for the fiscal year ended September 30, 2021, filed with the SEC on December 29, 2021. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by holding securities or otherwise, are contained in the proxy statement and other relevant documents to be filed with the SEC regarding the transaction. offered when available. You can obtain free copies of these documents as described in the preceding paragraph.

Brilliant and its directors and executive officers are participating in the solicitation of proxies from Brilliant shareholders with respect to the proposed transaction. Information about the directors and officers of Brilliant and their ownership of Brilliant common stock is set forth in Brilliant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on March 31. 2022. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by holding securities or otherwise, are contained in the proxy statement and other relevant documents to be filed with the SEC regarding the proposed transaction when available. You can obtain free copies of these documents as described above.

Forward-Looking Statements This press release contains forward-looking statements, which are based on estimates, assumptions and expectations. Actual results and performance could differ materially and adversely from those expressed or implied by the forward-looking statements. Brilliant and Nukkleus assume no obligation to update forward-looking statements except as required by law.

Contacts: Brilliant Acquisition Corporation Dr. Peng Jiang Chief Executive Officer Brilliant Acquisition Corporation + (86) 021-80125497


Florida judge strikes down US mask mandate for planes and other travel

Copyright 2022 GlobeNewswire, Inc.